Naftali Bechar

Primary mFOLFOX6 Plus Bevacizumab Without Resection of the Primary Tumor for Patients Presenting With Surgically Unresectable Metastatic Colon Cancer and an Intact Asymptomatic Colon Cancer: Definitive Analysis of NSABP Trial C-10

Laurence E. McCahill, Greg Yothers, Saima Sharif et al. · Journal of Clinical Oncology · 2012 · 164 citations · Full text

Medicine, Oncology, Surgery +17

Paclitaxel Plus Bevacizumab in Patients with Chemosensitive Relapsed Small Cell Lung Cancer: A Safety, Feasibility, and Efficacy Study from the Hoosier Oncology Group

Shadia I. Jalal, Pablo M. Bedano, Lawrence H. Einhorn et al. · Journal of Thoracic Oncology · 2010 · 52 citations · Full text

Medicine, Oncology, Pharmacology +9

A Pilot Study of Long-Acting Octreotide for Symptomatic Malignant Ascites

Aminah Jatoi, Jorgé Nieva, Rui Qin et al. · Oncology · 2012 · 24 citations

Medicine, Pharmacology, Pharmacotherapy +13

Preoperative cetuximab and radiation (XRT) for patients (pts) with surgically resectable esophageal and gastroesophageal junction (GEJ) carcinomas: A pilot study from the Hoosier Oncology Group and the University of Texas Southwestern

Anuj K. Agarwala, Nasser H. Hanna, A. McCollum et al. · Journal of Clinical Oncology · 2009 · 19 citations

Medicine, Oncology, Radiation Oncology +17

Basic Steps to Building a Research Program

Allison R. Baer, Naftali Bechar, Gary I. Cohen et al. · Journal of Oncology Practice · 2010 · 17 citations · Full text

Medicine, Health Policy, Health Services Administration +17